DOSAGE REGIMEN FOR A PI-3 KINASE INHIBITOR

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

HIRAWAT SAMIT,MASSACESI CRISTIAN

申请号：

TN2014000433

公开号：

TN2014000433A1

申请日:

2014.10.17

申请国别(地区):

TN

年份:

2016

代理人:

摘要：

The present invention relates to a dosage regimen for a phosphatidylinositol 3-kinase (PI3K) inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof. More specifically, the present invention relates to a dosage regimen for the treatment of patients suffering from a proliferative disease, such as, for example, cancer, with a phosphatidylinositol 3-kinase (PI3K) inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/